鞘内药物递送治疗终末期癌症疼痛：案例研究。
Intrathecal drug delivery for cancer pain at the end of life: a case study.
机构信息
Registered Nurse, The Royal Marsden, London.
Lecturer, King's College London.
出版信息
Br J Nurs. 2023 Mar 9;32(5):S16-S22. doi: 10.12968/bjon.2023.32.5.S16.
Two-thirds of patients with advanced cancer have pain and, of these, approximately 10-20% do not respond to conventional pain management approaches. This case study concerns a hospice patient who received intrathecal drug delivery for intractable cancer pain at the end of life. This involved working in partnership with a hospital-based interventional pain team. Despite side-effects and complications associated with intrathecal drug delivery and the requirement for inpatient nursing care, intrathecal drug delivery was the best option for the patient. The case identifies the importance of a patient-centred approach to decision-making, effective partnerships between hospice and acute hospital teams, and nurse education as key factors contributing to the provision of safe and effective intrathecal drug delivery.
三分之二的晚期癌症患者有疼痛症状，其中约 10-20%的患者对常规疼痛管理方法没有反应。本案例研究涉及一位临终前接受鞘内药物递送治疗难治性癌症疼痛的临终关怀患者。这需要与医院内介入性疼痛团队合作。尽管鞘内药物递送存在副作用和并发症，并且需要住院护理，但对于该患者而言，鞘内药物递送是最佳选择。该案例确定了以患者为中心的决策方法、临终关怀和急性医院团队之间的有效合作以及护士教育作为为安全有效的鞘内药物递送提供支持的关键因素的重要性。
Zotero 插件